Held the Taihu (Mashan) Life and Health Forum - 2018 biomedical and financial innovation.
Wuxi WuXi PharmaTech New Drug Development Co., Ltd. A shares listed.
Yaoming Biology is listed on the Hong Kong Stock Exchange.
The US FDA completed the pre-approval inspection of the Pharmacological BCI stock solution and the sterile preparation base.
WuXi PharmaTech started construction of the world's largest disposable bioreactor animal cell culture production base.
Academician Fu Xiaobing and Brady Biology set up an international regenerative medicine achievement transformation center to establish a workstation for Fu Xiaobing.
The International Stem Cell Joint Research Center has passed the international AABB certification.
The National Testing Center for Biological New Materials of the Chinese Academy of Sciences has settled.
Wuxi Yaoming Biological has built China's first cGMP biological research and development production base.